Advertisement

Protein Kinase C - the Key-Enzyme in Ischemic Preconditioning?

  • James M. Downey
  • Christof Weinbrenner
Chapter
  • 43 Downloads
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 194)

Abstract

Ischemic preconditioning of the heart is a phenomenon whereby one or more brief episodes of ischemia render the heart more resistant to injury from a subsequent longer ischemic insult. Preconditioning was originally described a decade ago as a protective intervention that reduced the area of necrosis from a standardized ischemic insult.1 Subsequently numerous studies have shown that preconditioning can also provide protection against other detrimental effects of ischemia, such as arrhythmia and possibly even postischemic contractile dysfunction as occurs in the stunned myocardium.2,3 There is of course no proof that the mechanisms responsible for the protective effects against necrosis, recovery of function and arrhythmias are all the same. In fact current evidence would suggest that the anti-arrhythmic and the anti-infarct effects are accomplished by quite different pathways. Ischemic preconditioning against infarction has been confirmed in every animal model that has been studied and there is considerable evidence, albeit indirect, that ischemic preconditioning also occurs in man.4 The actual mechanism of ischemic preconditioning has not yet been determined although considerable light has been shed on the signal transduction systems that are involved. Investigations in ischemic preconditioning have revealed that protection against infarction, at least in some species, is mediated through activation of protein kinase C (PKC), but it is not yet known how PKC is being activated nor what the final effector might be.5,6

Keywords

Ischemic Precondition Rabbit Heart Ischaemic Precondition MgATPase Activity Cardiac Myocyte Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124–1136.PubMedCrossRefGoogle Scholar
  2. 2.
    Lasley RD, Anderson GM, Mentzer RM. Ischemic and hypoxic preconditioning enhance postischemic recovery of function in the rat heart. Cardiovasc Res 1993;27:565–570.PubMedCrossRefGoogle Scholar
  3. 3.
    Lawson CS, Coltart DJ, Hearse DJ. “Dose ”-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol 1993;25:1391–1402.PubMedCrossRefGoogle Scholar
  4. 4.
    Lawson CS. Does ischemic preconditioning occur in the human heart. Cardiovasc Res 1994;28:1461–1466.PubMedCrossRefGoogle Scholar
  5. 5.
    Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145–H1152.PubMedGoogle Scholar
  6. 6.
    Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat heart? Am J Physiol 1995;268:H426–H431.PubMedGoogle Scholar
  7. 7.
    Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986;233:305–312.PubMedCrossRefGoogle Scholar
  8. 8.
    Stabel S, Parker PJ. Protein kinase C. Pharmac Ther 1991;51:71–95.CrossRefGoogle Scholar
  9. 9.
    Pears C, Parker PJ. Domain interactions in protein kinase C. J Cell Sci 1992; 100:683–686.Google Scholar
  10. 10.
    Flint AJ, Paladini RD, Koshland DEJ. Autophosphorylation of protein kinase C at three separated regions of its primary sequence. Science 1990;249:408–411.PubMedCrossRefGoogle Scholar
  11. 11.
    Mitchell FE, Marais RM, Parker PJ. The phosphorylation of protein kinase C as a potential measure of activation. Biochem J 1989;261:131–136.PubMedGoogle Scholar
  12. 12.
    Cazaubon SM, Parker PJ. Identification of the phosphorylated region responsible for the permissive activation of protein kinase C. J Biol Chem 1993;268:17559–17563.PubMedGoogle Scholar
  13. 13.
    Marais RM, Parker PJ. Purification and characterisation of bovine brain protein kinase C isotypes alpha, beta and gamma. Eur J Biochem 1989;182:129–137.PubMedCrossRefGoogle Scholar
  14. 14.
    Ono Y, Fujii T, Igarashi K, et al. Nucleotide sequences of cDNAs for alpha and gamma subspecies of rat protein kinase C. Nucl Acids Res 1988;16:5199–5200.PubMedCrossRefGoogle Scholar
  15. 15.
    Blobe GC, Khan WA, Halpern AE, et al. Selective regulation of expression of protein kinase C b isoenzymes occurs via alternative splicing. J Biol Chem 1993;268:10627–10635.PubMedGoogle Scholar
  16. 16.
    Ono Y, Fujii T, Ogita K, et al. Identification of three additional members of rat protein kinase C family: delta, epsilon and zeta subspecies. FEBS Lett 1987;226:125–128.PubMedCrossRefGoogle Scholar
  17. 17.
    Bacher N, Zisman Y, Berent E, et al. Isolation and characterization of PK.C-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart. Mol Cell Biol 1991;11:126–133.PubMedGoogle Scholar
  18. 18.
    Osada S, Mizuno K, Saido TC, et al. A new member of the protein kinase C family, nPKC-teta, predominantly expressed in skeletal muscle. Mol Cell Biol 1992;12:3930–3938.PubMedGoogle Scholar
  19. 19.
    Ono Y, Fujii T, Ogita K, et al. Protein kinase C-zeta subspecies from rat brain: Its structure, expression and properties. Proc Natl Acad Sci USA 1989;86:3099–3103.PubMedCrossRefGoogle Scholar
  20. 20.
    Johannes FJ, Prestle J, Eis S, et al. PKC-m is a novel, atypical member of the protein kinase C family. J Biol Chem 1994;269:6140–6148.PubMedGoogle Scholar
  21. 21.
    Selbie LA, Schmitz Peiffer C, Sheng Y, et al. Molecular cloning and characterization of PKC-iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem 1993;268:24296–24302.PubMedGoogle Scholar
  22. 22.
    Akimoto K, Mizuno R, Osada S, et al. A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J Biol Chem 1994;269:12677–12683.PubMedGoogle Scholar
  23. 23.
    Kohout TA, Rogers TB. Use of a PCR-based method to characterize protein kinase C isoform expression in cardiac cells. Am J Physiol 1993;264:C1350–C1359.PubMedGoogle Scholar
  24. 24.
    Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 1994;74:299–309.PubMedCrossRefGoogle Scholar
  25. 25.
    Kraft AS, Anderson WB. Phorbol esters increase the amount of Ca2+ phospholipid-dependent protein kinase associated with plasma membrane. Nature 1983;301:621–623.PubMedCrossRefGoogle Scholar
  26. 26.
    Noland TAJ, Kuo JF. Protein kinase C phosphorylation of cardiac troponin I and troponin T inhibits Ca2+-stimulated MgATPase activity in reconstituted actomyosin and isolated myofibrils, and decreases actin-myosin interactions. J Mol Cell Cardiol 1993;25:53–65.PubMedCrossRefGoogle Scholar
  27. 27.
    Noland TAJ, Kuo JF. Phosphorylation of cardiac myosin light chain 2 by protein kinase C and myosin light chain kinase increases Ca2+-stimulated actomyosin MgATPase activity. Biochem Biophys Res Commun 1993;193:254–260.PubMedCrossRefGoogle Scholar
  28. 28.
    Kawabe J, Iwami G, Ebina T, et al. Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 1994;269:16554–16558.PubMedGoogle Scholar
  29. 29.
    Katada T, Gilman AG, Watanabe Y, et al. Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem 1985; 151:431–437.PubMedCrossRefGoogle Scholar
  30. 30.
    Yatomi Y, Arata Y, Tada S, et al. Phosphorylation of the inhibitory guanine-nucleotide-binding protein as a possible mechanism of inhibition by protein kinase C of agonist-induced Ca2+ mobilization in human platelet. Eur J Biochem 1992;205:1003–1009.PubMedCrossRefGoogle Scholar
  31. 31.
    Richardson RM, Ptasienski J, Hosey MM. Functional effects of protein kinase C-mediated phosphorylation of chick heart muscarinic cholinergic receptors. J Biol Chem 1992;267:10127–10132.PubMedGoogle Scholar
  32. 32.
    Qu Y, Torchia J, Sen AK. Protein kinase C mediated activation and phosphorylation of Ca2+-pump in cardiac sarcolemma. Can J Physiol Pharmacol 1992;70:1230–1235.PubMedCrossRefGoogle Scholar
  33. 33.
    Grekinis D, Reimann EM, Schlender KK. Phosphorylation and inactivation of rat heart glycogen synthase by cAMP-dependent and cAMP-independent protein kinases. Int J Biochem Cell Biol 1995;27:565–573.PubMedCrossRefGoogle Scholar
  34. 34.
    Liu JD, Wood JG, Raynor RL, et al. Subcellular distribution and immunocytochemica! localization of protein kinase C in myocardium, and phosphorylation of troponin in isolated myocytes stimulated by isoproterenol or phorbol ester. Biochem Biophys Res Commun 1989;162:1105–1110.PubMedCrossRefGoogle Scholar
  35. 35.
    Speechly-Dick ME, Graver GJ, Yellon DM. Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995;77:1030–1035.PubMedCrossRefGoogle Scholar
  36. 36.
    Stumpo DJ, Graff JM, Albert KA, et al. Molecular cloning, characterization, and expression of cDNA encoding the “80-to 87-kDa ” myristoylated alanine-rich kinase substrate: a major cellular substrate for protein kinase C. Proc Natl Acad Sci USA 1989;86:4012–4016.PubMedCrossRefGoogle Scholar
  37. 37.
    Herget T, Oehrlein SA, Pappin DJC, et al. The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C. Eur J Biochem 1995,233:448–457.PubMedCrossRefGoogle Scholar
  38. 38.
    Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988;334:661–665.PubMedCrossRefGoogle Scholar
  39. 39.
    Cockcroft S, Geny B, Thomas GM. Regulation of cytosolic phosphoinositide-phospholipase C by G-protein, Gp. Biochem Soc Trans 1991;19:299–302.PubMedGoogle Scholar
  40. 40.
    Lamers JM, Dekkers DH, Bezstarosti K, Meij JT, van Heugten HA. Occurrence and functions of the phosphatidylinositol cycle in the myocardium. Mol Cell Biochem 1992;116:59–67.PubMedCrossRefGoogle Scholar
  41. 41.
    Billah MM, Anthes JC. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J 1990;269:281–291.PubMedGoogle Scholar
  42. 42.
    Berridge MJ. Inositol triphosphate and calcium signalling. Nature 1993;361:315–325.PubMedCrossRefGoogle Scholar
  43. 43.
    Conricode KM, Smith JL, Bums DJ, Exton JH. Phospholipase D activation in fibroblast membranes by the alpha and beta isoforms of protein kinase C. FEBS Lett 1994;342:149–153.PubMedCrossRefGoogle Scholar
  44. 44.
    Liu Y, Cordis GA, Das DK, Downey JM, Cohen MV. Protein kinase C may be activated by phospholipase D rather than C in ischemic preconditioning. J Mol Cell Cardiol 1995;27:A41 (abstract).Google Scholar
  45. 45.
    Alkhulaifi AM, Pugsley WB, Yellon DM. The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection. Cardioscience 1993;4:163–169.PubMedGoogle Scholar
  46. 46.
    Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993;27:542–550.PubMedCrossRefGoogle Scholar
  47. 47.
    Yang XM, Arnoult S, Tsuchida A, Cope D, Thornton JD, Daly JF, Cohen MV, Downey JM. The protection of ischemic preconditioning can be reinstated in the rabbit heart after the initial protection has waned. Cardiovasc Res 1993;27:556–558.PubMedCrossRefGoogle Scholar
  48. 48.
    Miura T, limura O. Infarct size limitation by preconditioning: it’ s phenomenological features and the key role of adenosine. Cardiovasc Res 1993;27:36–42.PubMedCrossRefGoogle Scholar
  49. 49.
    Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263:H1107–H1112.PubMedGoogle Scholar
  50. 50.
    Deutsch E, Berger M, Kussmaul WG, et al. Adaption to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1990;82:2044–2051.PubMedCrossRefGoogle Scholar
  51. 51.
    Przyklenk K, Bauer B, Ovize M, et al. Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893–899.PubMedCrossRefGoogle Scholar
  52. 52.
    Ovize M, Kloner RA, Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol 1994;266:H137–H146.PubMedGoogle Scholar
  53. 53.
    Yazaki Y, Komuro I, Yamazaki T, et al. Role of protein kinase system in the signal transduction of stretch-mediated protooncogene expression and hypertrophy of cardiac myocytes. Mol Cell Biochem 1993;119:11–16.PubMedCrossRefGoogle Scholar
  54. 54.
    Liu GS, Thornton JD, Van-Winkle DM, et al. Protection against infarction afforded by preconditioning is mediated by A1, adenosine receptors in rabbit heart. Circulation 1991;84:350–356PubMedCrossRefGoogle Scholar
  55. 55.
    Tsuchida A, Liu Y, Liu GS, et al. γ1-adrenergic agonists precondition rabbit ischemic myocardium independent of Adenosine by direct activation of protein kinase C. Circ Res 1994;75:576–585.PubMedCrossRefGoogle Scholar
  56. 56.
    Banerjee A, Locke-Winter C, Rogers KB, et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an γ1-adrenergic mechanism. Circ Res 1993;73:656–670.PubMedCrossRefGoogle Scholar
  57. 57.
    Goto M, Liu YG, Yang XM, et al. Role of Bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611–621.PubMedCrossRefGoogle Scholar
  58. 58.
    Brew EC, Mitchell MB, Rehring TF, et al. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol 1995;269:H1370–H1378.PubMedGoogle Scholar
  59. 59.
    Liu Y, Tsuchida A, Cohen MV, et al. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995;27:883–892.PubMedCrossRefGoogle Scholar
  60. 60.
    Yao Z, Gross GJ. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol 1993;264:H2221–H2225.PubMedGoogle Scholar
  61. 61.
    Thornton JD, Liu GS, Downey JM. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol 1993;25:311–320.PubMedCrossRefGoogle Scholar
  62. 62.
    Ganote CE, Armstrong S, Downey JM. Adenosine and A1, selective agonists offer minimal protection against ischaemic injury to isolated rat cardiomyocytes. Cardiovasc Res 1993;27:1670–1676.PubMedCrossRefGoogle Scholar
  63. 63.
    Cave AC, Collis CS, Downey JM, et al. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res 1993;27:663–668.PubMedCrossRefGoogle Scholar
  64. 64.
    Asimakis GK, Inners-McBride K, Conti VR, et al. Transient beta adrenergic stimulation can precondition the rat heart against postischaemic contractile dysfunction. Cardiovasc Res 1994;28:1726–1734.PubMedCrossRefGoogle Scholar
  65. 65.
    Weselcouch EO, Baird AJ, Sleph PG, et al. Endogenous catecholamines are not necessary for ischemic preconditioning in the isolated perfused rat heart. Cardiovasc Res 1995;29:126–132.PubMedGoogle Scholar
  66. 66.
    Schultz JEJ, Rose E, Yao Z, et al. Evidence for the involvement of opioid receptors in ischemic preconditioning in the rat heart. Am J Physiol 1995;268: H2157–H2161.PubMedGoogle Scholar
  67. 67.
    Niroomand F, Weinbrenner C, Weis A, et al. Impaired function of inhibitory G proteins during acute myocardial ischemia of canine hearts and its reversal during reperfusion and a second period of ischemia. Possible implications for the protective mechanism of ischemic preconditioning. Circ Res 1995;76:861–870.PubMedCrossRefGoogle Scholar
  68. 68.
    Piacentini L, Wainwright CL, Parratt JR. The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism. Cardiovasc Res 1993;27:674–680.PubMedCrossRefGoogle Scholar
  69. 69.
    Lawson CS, Coltart DJ, Hearse DJ. The antiarrhythmic action of ischemic preconditioning in rat hearts does not involve functional G1, proteins. Cardiovasc Res 1993;27:681–687.PubMedCrossRefGoogle Scholar
  70. 70.
    Liu Y, Downey JM. Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G protein. Cardiovasc Res 1993;27:608–611.PubMedCrossRefGoogle Scholar
  71. 71.
    Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 1994;75:586–590.PubMedCrossRefGoogle Scholar
  72. 72.
    Hu KL, Nattel S. Mechanisms of ischemic preconditioning in rat hearts. Involvement of a1b-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 1995;92:2259–2265.PubMedCrossRefGoogle Scholar
  73. 73.
    Simkhovich BZ, Whittaker P, Przyklenk K, et al. Transient pre-ischemic acidosis protects the isolated heart subjected to 30 minutes, but not 60 minutes, of global ischemia. Basic Res Cardiol 1995;90:397–403.PubMedCrossRefGoogle Scholar
  74. 74.
    Strasser RH, Simonis G, Weinbrenner C, et al. Ischemia-induced activation of protein kinase C: Evidence for an acidose-dependent, but energy-independent mechanism. Circulation 1994;90:I–208 (abstract).Google Scholar
  75. 75.
    Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26:661–668.PubMedCrossRefGoogle Scholar
  76. 76.
    Przyklenk K, Sussman MA, Simkhovich BZ, et al. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 1995;92:1546–1557.PubMedCrossRefGoogle Scholar
  77. 77.
    Vogt A, Barancik M, Weihrauch D, et al. Protection of ischemic porcine myocardium from infarction by an A 1-receptor agonist is not mediated by protein kinase C. Circulation 1994;90:I–371 (abstract).Google Scholar
  78. 78.
    Armstrong SC, Hoover DB, DeLacey MH, et al. Translocation of PKC, protein phosphatase inhibition and in vitro preconditioning of rabbit myocytes. J Mol Cell Cardiol 1996; (abstract).Google Scholar
  79. 79.
    Henry P, Demolombe S, Puceat M, et al. Adenosine A1, stimulation activates ö-protein kinase C in rat ventricular myocytes. Circ Res 1996;78:161–165.PubMedCrossRefGoogle Scholar
  80. 80.
    Mitchell MB, Meng X, Ao L, et al. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73–81.PubMedCrossRefGoogle Scholar
  81. 81.
    Armstrong S, Downey JM, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 1994;28:72–77.PubMedCrossRefGoogle Scholar
  82. 82.
    Armstrong S, Ganote CE. In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effects of selective adenosine receptor blockade and calphostin C. Cardiovasc Res 1995;29:647–652.PubMedGoogle Scholar
  83. 83.
    Armstrong S, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia. Cardiovasc Res 1994;28:1700–1706.PubMedCrossRefGoogle Scholar
  84. 84.
    Bogoyevitch MA, Parker PJ, Sugden PH. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res 1993;72:757–767.PubMedCrossRefGoogle Scholar
  85. 85.
    Weinbrenner C, Simonis G, Marquetant R, et al. Selective regulation of calcium-dependent and calcium-independent subtypes of protein kinase C in acute and prolonged ischemia. Circulation 1993;88:I–101 (abstract).Google Scholar
  86. 86.
    Kitakaze M, Node K, Minamino T, et al. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5’-nucleotidase. Circulation 1996;93:781–791.PubMedCrossRefGoogle Scholar
  87. 87.
    Rennollet H, Barancik M, Westemacher D, et al. The preconditioning-effect of PKC-stimulation is dose-, time-, and species-dependent. Circulation 1994;90:I–371 (abstract).Google Scholar
  88. 88.
    Black SC, Fagbemi SO, Chi L, et al. Phorbol-ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide. J Mol Cell Cardiol 1993;25:1427–1438.PubMedCrossRefGoogle Scholar
  89. 89.
    Strasser RH, Braun Dullaeus R, Walendzik H, et al. α-receptor-independent activation of protein kinase C in acute myocardial ischemia. Circ Res 1992;70:1304–1312.PubMedCrossRefGoogle Scholar
  90. 90.
    Kirsch GE, Codina J, Bimbaumer L, et al. Coupling of ATP-sensitive K+ channels to A1-receptors by G-proteins in rat ventricular myocytes. Am J Physiol 1990;259:H820–H826.PubMedGoogle Scholar
  91. 91.
    Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223–233.PubMedCrossRefGoogle Scholar
  92. 92.
    Thornton JD, Thornton CS, Sterling DL, et al. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 1993;72:44–49.PubMedCrossRefGoogle Scholar
  93. 93.
    Walsh RS, Tsuchida A, Daly JJF, et al. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myoardium. Cardiovasc Res 1994;28:1337–1341.PubMedCrossRefGoogle Scholar
  94. 94.
    Toombs CF, McGee DS, Johnston WE, et al. Protection from ischemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels. Cardiovasc Res 1993;27:623–629.PubMedCrossRefGoogle Scholar
  95. 95.
    Armstrong SC, Liu GS, Downey JM, et al. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol 1995;27:1765–1774.PubMedCrossRefGoogle Scholar
  96. 96.
    Graver GJ, Dzwonczyk S, Sleph PG. ATP-sensitive K’-channel activation does not mediate preconditioning in isolated rat hearts. Circulation 1992;86:I–341 (abstract).Google Scholar
  97. 97.
    Liu Y, Gao WD, O’Rourke B, et al. Synergistic modulation of ATP-sensitive K+currents by protein kinase C and adenosine. Implications for ischemic preconditioning. Circ Res 1996;78:443–454.PubMedCrossRefGoogle Scholar
  98. 98.
    Tomai F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994;90:700–705.PubMedCrossRefGoogle Scholar
  99. 99.
    Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276–277.PubMedCrossRefGoogle Scholar
  100. 100.
    Ikonomidis JS, Shirai T, Weisel RD, et al. “Ischemic ”or adenosine preconditioning of human ventricular cardiomyocytes is protein kinase C dependent. Circulation 1995;92:I–12 (abstract).Google Scholar
  101. 101.
    Wetsel WC, Khan WA, Merchenthaler I, et al. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 1992;117:121–133.PubMedCrossRefGoogle Scholar
  102. 102.
    Gu X, Bishop SP. Protein kinase isoenzyme expression in the developing rat heart and changes in expression in response to pressure overload hypertrophy. J Mol Cell Cardiol 1994;27:CLXVI (65) (abstract).Google Scholar
  103. 103.
    Puceat M, Hilal Dandan R, Strulovici B, et al. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem 1994;269:16938–16944.PubMedGoogle Scholar
  104. 104.
    Disatnik MH, Buraggi G, Mochly Rosen D. Localization of protein kinase C isoenzymes in cardiac myocytes. Exp Cell Res 1994;210:287–297.PubMedCrossRefGoogle Scholar
  105. 105.
    Clerk A, Bogoyevitch MA, Fuller SJ, et al. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol 1995;269:H1087–H1097.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • James M. Downey
  • Christof Weinbrenner

There are no affiliations available

Personalised recommendations